Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global X Copper Miners ETF (COPX) vs Cognizant Technology Solutions Corp (CTSH) Price & Performance

Global X Copper Miners ETFTrade
Cognizant Technology Solutions CorpTrade

Price performance (Past 24H)

Key statistics

Global X Copper Miners ETF vs Cognizant Technology Solutions Corp — how do they compare? Global X Copper Miners ETF trades at $84.47 (market cap $7.37B), while Cognizant Technology Solutions Corp trades at $60.12 (market cap $25.71B). The key difference: Cognizant Technology Solutions Corp is far larger — about 3.5× Global X Copper Miners ETF's market cap, and Cognizant Technology Solutions Corp pays a 2.31% dividend while Global X Copper Miners ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Global X Copper Miners ETF for 50 Days and Cognizant Technology Solutions Corp for 57 Days on average.

COPXCTSH
Market Cap
$7.37B$25.71B
Volume
1,988,5325,152,376
Sector
Commodities - Metals/AgricultureTechnology
52-Week High
$96.45$86.70
52-Week Low
$57.43$38.73
Typical Hold Time
50 Days57 Days
Enterprise Value
—$26.75B
Dividend Yield
—2.31%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Global X Copper Miners ETF

COPX (Global X Copper Miners ETF) is trading at $83.58, down 3.13% with a bearish technical signal. The ETF faces selling pressure with 15 sell signals versus 2 buy signals across technical indicators. Copper fundamentals remain strong with prices near all-time highs above $6.85 per pound, driven by AI infrastructure demand and supply constraints. Recent news highlights copper's critical role in electrification and AI infrastructure, though technical indicators suggest near-term weakness.

The long-term copper thesis remains compelling due to structural supply deficits and AI-driven demand growth. However, near-term risks include potential Federal Reserve policy impacts and mining equity underperformance relative to copper prices. The ETF offers operational leverage to copper prices but faces volatility from global surplus projections and macroeconomic factors.

Cognizant Technology Solutions Corp

Cognizant Technology Solutions (CTSH) trades at $57.07, down 0.26% with bearish technical signals despite recent earnings beats. The stock shows attractive valuation metrics with P/E of 12.25 and EV/EBITDA of 6.52, while maintaining solid profitability with 10.26% net margin. Recent news highlights the company's AI transformation initiatives and recognition as a top employer, though Q2 2026 earnings missed expectations.

CTSH presents a compelling value opportunity with strong fundamentals and analyst consensus target of $64.25 (12.6% upside). Risks include IT spending pressures from AI disruption and competitive threats. The upcoming Q3 2026 earnings report on October 29, 2026 will be critical for validating the company's growth trajectory amid industry headwinds.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

COPX
100% Buy0% Sell
Avg holding period · 50 Days
CTSH
100% Buy0% Sell
Avg holding period · 57 Days

Top news

Latest headlines on both assets

About Global X Copper Miners ETF

COPX tracks the Solactive Global Copper Miners Total Return Index, providing broad exposure to companies worldwide involved in copper mining, refining, and exploration. It serves as an equity-based alternative to copper futures, offering a leveraged play on copper demand driven by global infrastructure and the clean energy transition.

Read more on COPX →

About Cognizant Technology Solutions Corp

Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 300,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.

Read more on CTSH →